Pamela Lentz
Nurse Practitioner · Baltimore, MDNPI 1932181534
Payments from drug & device makers
Across 65 payments — averaging $29.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$560
- Johnson & Johnson$241
- Amgen$196
- AstraZeneca$147
- Novartis$145
- Novo Nordisk$98
- plus $558 from 14 others
What the payments were for
- Food & beverage$1,79192%
- Education$1558%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 20 | $560 |
| Johnson & Johnson | 5 | $241 |
| Amgen | 9 | $196 |
| AstraZeneca(2 entities) | 3 | $147 |
| Novartis | 5 | $145 |
| Novo Nordisk | 1 | $98 |
| UCB, Inc. | 2 | $60 |
| Aurinia Pharma U.S., Inc. | 2 | $57 |
| E.r. Squibb & Sons, L.L.C. | 3 | $57 |
| Solventum Corporation | 1 | $55 |
| Invivyd Inc | 2 | $52 |
| Pfizer | 2 | $50 |
| Lilly USA, LLC | 2 | $49 |
| Radius Health, Inc. | 2 | $34 |
| Fresenius Kabi USA, LLC | 1 | $32 |
| Boehringer Ingelheim | 1 | $29 |
| GSK | 1 | $28 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $24 |
| Kyowa Kirin, Inc. | 1 | $18 |
| Genentech USA, Inc. | 1 | $14 |
How this compares
$1,946 in reported general payments places this provider in the 90th percentile of 1,562 nurse practitioner providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 12 | $161,423 |
| RinvoqUpadacitinib | 20 | $141,539 |
| SimponiGolimumab | 12 | $74,446 |
| OxycontinOxycodone Hcl | 15 | $5,886 |
| Hydroxychloroquine Sulfate | 122 | $5,608 |
| MethotrexateMethotrexate Sodium | 153 | $4,288 |
| Leflunomide | 36 | $2,687 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 69 | $1,926 |
| Gabapentin | 42 | $1,513 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 35 | $1,072 |
| Celecoxib | 31 | $922 |
| Duloxetine Hcl | 37 | $907 |
| Tramadol Hcl | 75 | $611 |
| Pantoprazole Sodium | 11 | $567 |
| Folic Acid | 24 | $471 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq | $560 | $141,53920 claims |
| Johnson & JohnsonSimponi | $241 | $74,44612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,562 nurse practitioner providers in Maryland.
Other nurse practitioner in Baltimore
- Sherilyn BrinkleyBaltimore$100K
- Michelle TurnerBaltimore$94K
- Zeev NemirovskyBaltimore$19K
- Stephanie HorrocksBaltimore$12K
- Sandra WoodringBaltimore$12K
- Inna BardoffBaltimore$11K
- Linda RyanBaltimore$10K
- Laura HostovichBaltimore$8K
- Denese GaughanBaltimore$7K
- Arita McCoyBaltimore$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.